Vasculitis Guideline
Guideline Status
Step 10: Final guideline published and disseminated
See a list of all clinical practice guideline project steps on the Clinical Practice Guidelines page.
On This Page
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Documents related to the 2021 guideline:
Appendix 1 – Methods 2021
Appendix 2 – Evidence Report 2021
Appendix 3 – Dose Regimen 2021
Appendix 4 – Panel /Teams 2021
Appendix 5 – Search Strategies 2021
Appendix 6 – Study Selection 2021
Project Plan 2021
*Relates to all guidelines on this page
Public Comments 2021
*Relates to all guidelines on this page
Core Leadership Team Response to Public Comments 2021
*Relates to all guidelines on this page
Literature review published separately:
Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis of Test Accuracy and Benefits and Harms of Common Treatments
Granulomatosis With Polyangiitis and Microscopic Polyangiitis: A Systematic Review and Meta-Analysis of Benefits and Harms of Common Treatments
2021 Giant Cell Arteritis and Takayasu Arteritis Guideline
Documents related to the 2021 guideline:
Appendix 1 – Methods 2021
Appendix 2 – Evidence Report 2021
Appendix 3 – Panel/Teams 2021
Appendix 4 – Search Strategies 2021
Appendix 5 – Study Selection 2021
Literature review published separately:
Takayasu Arteritis: A Systematic Review and Meta-Analysis of Test Accuracy and Benefits and Harms of Common Treatments
Giant Cell Arteritis: A Systematic Review and Meta-Analysis of Test Accuracy and Benefits and Harms of Common Treatments
2021 Polyarteritis Nodosa Guideline
Documents related to the 2021 guideline:
Appendix 1 – Methods 2021
Appendix 2 – Evidence Report 2021
Appendix 3 – Panel/Teams 2021
Appendix 4 – Search Strategies 2021
Appendix 5 – Study Selection 2021
Literature review published separately:
Polyarteritis Nodosa: A Systematic Review of Test Accuracy and Benefits and Harms of Common Treatments
2021 Kawasaki Disease Guideline
Documents related to the 2021 guideline:
Appendix 1 – Methods 2021
Appendix 2 – Evidence Report 2021
Appendix 3 – Panel/Teams 2021
Appendix 4 – Search Strategies 2021
Appendix 5 – Study Selection 2021
Patient-Friendly, Plain-Language Recommendations
The ACR/VF Clinical Practice Guidelines were written for medical practitioners to help guide them in their treatment of patients with vasculitis. The plain-language versions of these guidelines focus on the information that is most important for the majority of patients to know and are written in language that can be easily understood by those who do not have a medical background. Find the patient-friendly, plain-language recommendations on the Vasculitis Foundation website.